Ad libitum feeding of silkworm larvae powder-containing diets specifically influences metabolism-related and short-chain fatty acid-producing gut bacteria in mice
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1383774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Aito Murakami und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Minamiminowa, Kamiina, Nagano, Japan. Hauptthemen laut MEDLINE: Bombyx, Gastrointestinal Microbiome, Larva, Fatty Acids, Volatile. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Silkworm ( Bombyx mori ) larvae are expected to be useful as an ingredient in entomophagy. They are full of nutrients, including indigestible proteins; however, there have been few studies on the effects of the consumption of the entire body of silkworms on the intestinal microflora. We prepared a customized diet containing silkworm larval powder (SLP), and investigated the effects of ad libitum feeding of the SLP diet on the intestinal microbiota and the amount of short-chain fatty acids (SCFAs) in mice. We found that the diversity of the cecal and fecal microbiota increased in the mice fed the SLP diet (SLP group), and that the composition of their intestinal microbiota differed from that of the control mice. Furthermore, a genus-level microbiota analysis showed that in the SLP group, the proportions of Alistipes , Lachnospiraceae A2, and RF39, which are associated with the prevention of obesity, were significantly increased, while the proportions of Helicobacter and Anaerotruncus , which are associated with obesity, were significantly decreased. Additionally, the level of butyrate was increased in the SLP group, and Clostridia UCG 014 and Lachnospiraceae FCS020 were found to be associated with the level of butyrate, one of the major SCFAs. These findings indicated that silkworm powder may be useful as an insect food that might also improve obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Minamiminowa, Kamiina, Nagano, Japan.
- Food and Feed Immunology Group, Laboratory of Animal Food Function, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.
- Faculty of Textile Science and Technology, Shinshu University, Ueda, Nagano, Japan.
- Morus Inc., Higashigotanda, Shinagawa-ku, Tokyo, Japan.
- Department of Medical Research on Prebiotics and Probiotics, Fujita Health University, Toyoake, Aichi, Japan.
Zitieren
APA
Murakami, A., Yamaguchi, H., Namai, F., Sato, T., Yamazaki, M., Uehara, H., Fujii, T., Tochio, T., Shiomi, K., & Shimosato, T. (2024). Ad libitum feeding of silkworm larvae powder-containing diets specifically influences metabolism-related and short-chain fatty acid-producing gut bacteria in mice. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1383774
Vancouver
Murakami A, Yamaguchi H, Namai F, Sato T, Yamazaki M, Uehara H, et al. Ad libitum feeding of silkworm larvae powder-containing diets specifically influences metabolism-related and short-chain fatty acid-producing gut bacteria in mice. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1383774
BibTeX
@article{Murakami2024,
author = {Murakami, Aito and Yamaguchi, Haruka and Namai, Fu and Sato, Takashi and Yamazaki, Maki and Uehara, Hiroshi and Fujii, Tadashi and Tochio, Takumi and Shiomi, Kunihiro and Shimosato, Takeshi},
title = {Ad libitum feeding of silkworm larvae powder-containing diets specifically influences metabolism-related and short-chain fatty acid-producing gut bacteria in mice},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1383774}
}
EUVIMED